Pentagon Issues Testosterone Screening Guidance for Male Troops
Left 50%
Center 0%
Right 50%
1 left · 0 center · 1 right
What happened
The Pentagon issued new clinical guidance late Thursday requiring mandatory testosterone-deficiency screening for male active-duty and reserve service members over age 30, about two weeks after it temporarily removed earlier hormone-screening documents from a Department of Defense website. A top adviser to Defense Secretary Pete Hegseth described those earlier postings as a "draft" that had been "inadvertently" posted; they had also directed that female service members be asked about fatigue and disrupted menstrual cycles associated with hormonal dysregulation. Under the new guidelines, men over 30 receive a structured symptom and risk assessment and two separate morning fasting testosterone blood tests, with an LH/FSH panel on the repeat draw and free-testosterone testing when total levels are in range; men under 30 may be screened on request. Pentagon spokesman Sean Parnell said the guidance "establishes uniform screening and treatment pathways across the DHA enterprise" and that identifying and treating "suboptimal hormone levels" invests in warfighter health and "force readiness"; female-service-member guidance is "being reviewed and will be posted upon approval." Earlier this year Hegseth announced annual testosterone testing for troops; service members already had access to testing and replacement therapy through Tricare, but such screenings had not been part of annual military health assessments.
Sourcing check · Mostly on the record · 2 articles
1 of 2 articles cite a named source for the story. It started with unnamed sources; a named source appeared 5 hours later.
What these terms mean and how they're counted
- On the record · names a source 1 of 2
- On the record means the article cites a source by name for the story's main claim: a person, or an institution speaking officially, such as a company statement or a named agency's spokesperson. The opposite is an unnamed source. The count is how many of the counted articles cite at least one such source; the names are everyone named across them, each once however the articles spell it. Here: Sean Parnell
- Primary evidence · cites a document or data 0 of 2
- Primary evidence means the article cites a record you could check yourself: a court filing or ruling, a dataset or report, a recording or transcript, an official statement or press release, market data. A quote is not a document. The count is how many articles cite one. Here: None cited.
- Credits another outlet 0 of 2
- The article says the story comes from another outlet's reporting (“first reported by Reuters”). Those articles relay the story; they are not independent confirmation. Here: Each article presents its own reporting.
- Unnamed sources 0 of 2
- The main claim is attributed to people who are not identified: “people familiar with the matter”, “officials said”. The count is how many articles do this.
- How it developed
- When the first report landed and whether it named anyone; when the first named source and the first document appeared. Here: First report Sep 18, 15:45 UTC by Washington Examiner, with no named source. First named source 5 hours later, from ABC News.
- Not counted 0
- Opinion, analysis and video pieces, and articles too short to assess. Every count above is out of the counted articles. An article republished under a new headline is one article.
This is about who is cited, not whether the story is true. Each source below says what it names. How we count
Omitted — what each side leaves out
Unpacked
Right-leaning coverage presents the new male screening rules as excluding women from hormone protocols, while left-leaning coverage reports women's guidance is still being written. A reader of ABC News is told female guidance is "being reviewed and will be posted upon approval." The withdrawn posting, in that account, had told clinicians to ask female service members about fatigue and disrupted menstrual cycles. A reader of the Washington Examiner is told similar best practices for women were omitted after initial protocols for both sexes were withdrawn.
Right-leaning coverage brands the policy Hegseth's "High-T" Department of War guidance. Left-leaning coverage describes Pentagon guidance for "testosterone deficiency screening."
None of the coverage says how the reissued male protocol differs from the document pulled two weeks earlier.
Bottom line
ABC News reports the Pentagon still has not posted women's hormone guidance; the Washington Examiner reports that guidance was left out of the new male testosterone screening.
The receipts — 4 facts one side's coverage lacks
- New guidelines say guidance for female service members is being reviewed and will be posted upon approval
- A top adviser described the pulled website documents as a draft that had been inadvertently posted
- Mandatory testosterone deficiency screening applies to male service members over the age of 30
- The account refers to the Pentagon as the Department of War
The Left View
ABC News and The Hill emphasize remaining medical and career uncertainties around the reissued male-only mandate. ABC reports that some doctors worry the online popularity of "low-T" "creates a false impression that this is a bigger problem than it really is," and cites American Urological Association figures that testosterone testing and prescribing have tripled, that up to 25% of men who receive therapy "do not have their levels properly tested," and that "up to a third of men who are put on testosterone therapy do not meet the criteria for a medical diagnosis," which the AUA says requires both symptoms and two separate early-morning low measurements. The coverage notes it is unclear what levels the Pentagon would find acceptable and "whether troops with lower levels could face professional consequences," while recording that female guidance from the withdrawn draft is still pending.
The Right View
The Washington Examiner frames the reissued protocol as Hegseth's "'High-T' Department of War guidance" that "finalized clinical guidance for testosterone screening for male service members, but left out similar best practices for treating women in the military for hormone disruptions that might affect performance." It stresses that the Pentagon reissued male-only screening roughly two weeks after withdrawing "its initial hormone replacement protocols for both men and women in uniform," presenting the omission of women's hormone-replacement best practices as the central feature of the finalized document.
Our Take (balanced)
The left-leaning coverage's strongest point is empirical caution about overtreatment: AUA-linked findings that testing and prescribing have tripled and that up to a third of men placed on testosterone therapy do not meet diagnostic criteria, paired with unanswered questions about cutoff levels and whether low results could affect a service member's career. The right-leaning coverage's strongest point is the documented asymmetry in the reissued text: after a withdrawn draft that addressed both sexes, the department published uniform male screening and treatment pathways while stating women's guidance remains under review, which the Examiner treats as leaving out "similar best practices" for hormone disruptions that "might affect performance." The central unresolved tension is whether the men-only reissue is a pending, readiness-driven medical protocol or a selective hormone policy that risks over-medicalizing male troops while deferring parallel care for women.
3 sources
More stories
The week's bottom lines, in your inbox
One email a week: the five stories that mattered and what they actually mean. Free.